# US 2008/0187954 A1 · Method For Producing Antibodies

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0187954 A1
- Document ID: US20080187954A1
- Status: Published application
- Kind: A1
- Application number: 10/591,812
- Filed: 2005-03-10
- Published: 2008-08-07
- Earliest claimed: 2004-03-10
- Assignees: Lonza Ltd.; Lonza Biologics PLC
- Inventors: Robert Kallmeier; Gilles Reiss; Robert Gay; Stephan Kalwy
- Web page: https://patentgrep.com/patent/US20080187954A1

## CPC

- C07K 16/30: from tumour cells
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K 2317/24: containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
- C07K 2319/00: Fusion polypeptide
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A novel method for expression of immunoglobulines is devised.

## Claims

### Claim at position 1

1-57. (canceled)

### Claim 58

Method for producing an immunoglobulin having Fc receptor activity and/or complement activation activity which immunoglobulin molecule when secreted from a vertebrate host cell comprises at least a first and a second polypeptide chain wherein the first polypeptide is an Ig-Light Chain (L) comprising at least a VL and a CL domain and in that the second polypeptide is an Ig-Heavy Chain (H) comprising at least a VH, CH2 and CH3 domain and a hinge domain, comprising the steps of
a. expressing in a vertebrate host cell having Golgi-only or late-Golgi-only resident furin family endoprotease activity a fusion polypeptide comprising a secretion targeting sequence directing the polypeptide to the secretory pathway and further comprising at least the said first and second polypeptide sequences and at least one cleavage site for the said endoprotease activity and wherein the fusion polypeptide comprises the sequences of said first and second polypeptide separated by a linker and
b. having the fusion polypeptide cleaved in the cells by the furin family endoprotease activity into the first and second polypeptide chains and
c. harvesting the secreted immunoglobulin.

### Claim 59 (depends on 58)

Method according to claim 58, characterized in that the Ig molecule comprises a CH1 domain.

### Claim 60 (depends on 58)

Method according to claim 58, characterized in that the Light and Heavy Chain are separated by a linker, in that the fusion polypeptide comprises at least two cleavage sites for the furin family endoprotease activity and in that the linker is cleaved off from both Heavy and Light Chain by the furin family endoprotease activity by means of said two cleavage sites.

### Claim 61 (depends on 58)

Method according to claim 58, characterized in that the furin family endoprotease activity is an activity naturally present in that host cell line.

### Claim 62 (depends on 58)

Method according to claim 58, characterized in that the host cell is devoid of furin family endoprotease activity in the endoplasmic reticulum.

### Claim 63 (depends on 58)

Method according to claim 58, characterized in that the furin family endoprotease activity is furin endoprotease or lymphoma proprotein convertase or a functional variant thereof.

### Claim 64 (depends on 58)

Method according to claim 58, characterized in that the furin family endoprotease activity is a constitutive endoprotease activity.

### Claim 65 (depends on 58)

Method according to claim 58, characterized in that the host cell line is a mammalian cell line.

### Claim 66 (depends on 65)

Method according to claim 65, characterized in that the host cell has at least one recombinant furin family endoprotease activity which is a homologously expressed mammalian furin family endoprotease naturally present in that host cell line which further is an constitutive furin family endoprotease or furin family endoprotease belonging to constitutive secretion, in this way achieving an elevated expression level of the natural gene product in its native host cell environment.

### Claim 67 (depends on 65)

Method according to claim 65, characterized in that the mammalian host cell line are CHO cells.

### Claim 68 (depends on 58)

Method according to claim 58, characterized in that the cleavage sites is a contiguous tetrapeptide sequence comprising at least three basic residues selected from the group consisting of arginine and lysine.

### Claim 69 (depends on 68)

Method according to claim 68, characterized in that the tetrapeptide sequence comprises four basic residues selected from the group consisting of arginine and lysine.

### Claim 70 (depends on 58)

Method according to claim 58, characterized in that the linker is a non-naturally occurring amino acid sequence.

### Claim 71 (depends on 58)

Method according to claim 58, characterized in that the linker comprises at least 20 amino acids.

### Claim 72 (depends on 71)

Method according to claim 71, characterized in the linker comprises one or several oligomers consisting of only glycine and either serine, threonine or both.

### Claim 73 (depends on 72)

Method according to claim 72, characterized in that the linker consists of one or several oligomers consisting of only glycine and either serine, threonine or both.

### Claim 74 (depends on 72)

Method according to claim 72, characterized in that the linker comprises at least >60% glycine residues.

### Claim 75

Method for producing an immunoglobulin having Fc receptor activity and/or complement activation activity which immunoglobulin molecule when secreted from a vertebrate host cell comprises at least a first and a second polypeptide chain wherein the first polypeptide is an Ig-Light Chain (L) comprising at least a VL and a CL domain and in that the second polypeptide is an Ig-Heavy Chain (H) comprising at least a a VH, CH2 and CH3 domain and a hinge domain, comprising the steps of
a. expressing in a vertebrate host cell having Golgi-only or late-Golgi-only resident subtilisin/kexin family endoprotease activity a fusion polypeptide comprising a secretion targeting sequence directing the polypeptide to the secretory pathway and further comprising at least the first and second polypeptide sequences and at least one cleavage site for the said endoprotease activity and wherein the fusion polypeptide comprises the sequences of said first and second polypeptide separated by a linker, and
b. having the fusion polypeptide cleaved in the cells by the subtilisin/kexin family endoprotease activity into the first and second polypeptide chains and
c. harvesting the secreted immunoglobulin.
